ALGS vs FAST · rev $3.6M vs P/E 43, rev $7.55B
Aligos Therapeutics Inc (ALGS) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
ALGS currently screens at market cap $44.1M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the ALGS and FAST stock pages for the full models.
Not investment advice.